• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Tata Communications Ltd
Industry :  Telecommunications - Service Provider
BSE Code
ISIN Demat
Book Value()
500483
INE151A01013
371.1821053
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATACOMM
72.38
56002.5
EPS(TTM)
Face Value()
Div & Yield %
27.15
10
0.89
 

Ajanta Pharma's Paithan unit concludes USFDA inspection
Apr 22,2026
Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.